No regulatory agency has established an official safe and effective dose for apigenin supplements, and no large human trial has tested isolated apigenin at a range of doses to pin one down. What exists instead is a patchwork: dietary intake data showing most people consume only a few milligrams a day from food, animal studies suggesting a wide safety margin at low-to-moderate doses but liver damage at high ones, and a handful of human trials using chamomile extract (which contains apigenin alongside other compounds) at doses that translate to roughly 3–15 mg of apigenin per day. Supplement manufacturers commonly sell capsules at 50 mg, a dose that sits well above typical dietary intake but far below the thresholds that caused harm in mice. That gap between “what people take” and “what has been rigorously tested in humans” is the honest state of the evidence.
What a Typical Diet Provides
Apigenin is a flavonoid found naturally in parsley, chamomile, celery, and kumquats, among other plant foods.1PubMed Central. Role of Apigenin in Cancer Prevention via the Induction of Apoptosis and Autophagy Most people eat very little of it. The European average sits around 3 mg per day, according to data from the European Food Safety Authority. In China, the figure is about 4 mg per day. Among middle-aged and older women in the United States, estimates range from as low as 0.13 mg to about 1.35 mg daily.2Hindawi (BioMed Research International). A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota – Section: Dietary Source and Daily Intake Levels Those numbers put typical apigenin intake at single-digit milligrams at most, and often under one milligram.
This matters for context because supplement capsules routinely contain 50 mg or even 100 mg of apigenin per serving. That is roughly 10 to 30 times what most people get from food. When someone asks whether 50 mg a day is safe, they are really asking whether a dose far outside normal dietary experience has been studied carefully in people. The short answer is that it has not been studied in isolation at that dose in any sizable human trial.
What Human Trials Have Actually Tested
Almost all of the human clinical data on apigenin comes from studies that used chamomile extract rather than pure apigenin. Chamomile is one of the richest natural sources of apigenin, but an extract contains many other compounds too, so it is impossible to attribute the results solely to apigenin. Still, these trials are the closest thing we have to controlled evidence in people.
In one randomized trial of 57 people with generalized anxiety disorder, participants received 220 mg of pharmaceutical-grade chamomile extract (standardized to 1.2% apigenin, or about 2.6 mg of apigenin per capsule) three times daily for eight weeks. The chamomile group showed a meaningful reduction in anxiety scores compared to placebo.3PubMed Central. A Randomized, Double-Blind, Placebo-Controlled Trial of Oral Matricaria Recutita (Chamomile) Extract Therapy of Generalized Anxiety Disorder A follow-up study extended treatment to 26 weeks, then randomized people who had responded to either continue chamomile or switch to placebo. Those who stayed on chamomile had fewer relapses and reported better psychological well-being, though the difference in relapse rates did not reach statistical significance.4PubMed Central. Long-term Chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial A systematic review of ten clinical trials similarly concluded that chamomile appears to have an anxiety-reducing effect, with apigenin thought to play a role by influencing neurotransmitter pathways.5PubMed Central. The Effect of Oral Chamomile on Anxiety: A Systematic Review of Clinical Trials
The daily apigenin dose in those anxiety studies, spread across three capsules of standardized extract, worked out to roughly 8–10 mg. That is above what most people eat but still well within single-digit to low-double-digit territory.
For sleep, the evidence is weaker. A pilot study of 34 people with chronic insomnia tested 270 mg of chamomile extract twice daily for 28 days. Chamomile shortened the time it took to fall asleep by about 16 minutes on average, but the primary measures of sleep quality showed no significant difference from placebo, and total sleep time actually favored the placebo group slightly.6PubMed Central. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: A randomized placebo-controlled pilot study A broader review noted that dietary apigenin intake correlates with better sleep quality in large population surveys, but correlation is not causation, and the apigenin doses involved were dietary-level, not supplement-level.7PubMed Central. Apigenin: a natural molecule at the intersection of sleep and aging
The honest summary is that the strongest human evidence supports chamomile extract, not isolated apigenin, for anxiety rather than sleep, at doses that deliver roughly 8–10 mg of apigenin daily. Whether higher doses would work better, or whether apigenin alone (stripped of the other chamomile compounds) would produce the same effects, remains untested in people.
Why Bioavailability Matters for Dosing
One reason the dose question is hard to answer is that apigenin does not absorb particularly well on its own. When taken orally, its bioavailability is around 30%, meaning roughly a third of what you swallow actually reaches your bloodstream. Peak blood levels occur within about half an hour to two and a half hours, and the compound clears relatively quickly, with a half-life averaging about two and a half hours.8PubMed Central. Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers?
That short half-life means apigenin does not linger in the body the way fat-soluble vitamins do, which cuts both ways. On the safety side, even if you take more than you need, the excess clears fairly fast. On the efficacy side, a single daily dose might not maintain meaningful blood levels throughout the day, which could explain why chamomile tea (sipped repeatedly) or multiple-capsule dosing schemes have been used in trials.
Researchers have experimented with delivery systems to improve absorption. Self-nanoemulsifying formulations have boosted the bioavailability of apigenin in animal models by roughly three to four times compared to plain powder.9PubMed Central. Enhancing Oral Bioavailability of Apigenin Using a Bioactive Self-Nanoemulsifying Drug Delivery System (Bio-SNEDDS): In Vitro, In Vivo and Stability Evaluations These are not consumer products yet, but some supplement companies already market “enhanced absorption” apigenin formulations. If those formulations genuinely do improve bioavailability, the effective dose drops and the safety margin shifts. Without standardized testing, though, you cannot assume that every product labeled “enhanced” actually delivers more apigenin to your bloodstream.
What Animal Studies Say About Safety Limits
The most direct toxicity data comes from a mouse study that tested single doses of apigenin ranging from 25 mg per kilogram of body weight up to 200 mg/kg. At 25 and 50 mg/kg, liver enzyme levels stayed normal and liver tissue looked healthy under a microscope. At 100 and 200 mg/kg, markers of liver damage spiked, and the liver tissue itself showed cell swelling and degeneration.10PubMed Central. Acute Exposure of Apigenin Induces Hepatotoxicity in Swiss Mice
Scaling mouse doses to humans is not straightforward and should not be done by simple body-weight math alone. But using standard conversion methods, 50 mg/kg in a mouse translates very roughly to around 4 mg/kg in a human, which for a 70-kg person would be about 280 mg. The toxic threshold in mice (100 mg/kg) would scale to something in the neighborhood of 560 mg for a 70-kg human. These numbers are crude estimates and should be treated as rough guardrails rather than precise limits. They suggest that a 50 mg supplement capsule sits comfortably below the zone where liver problems appeared in mice, but taking handfuls of capsules could push into less charted territory.
Importantly, that mouse study tested single acute exposures rather than chronic daily use. Most people asking about apigenin dose are planning to take it every day for weeks or months. Chronic low-dose toxicity data in any species is sparse, which is a genuine gap in the evidence.
How Apigenin Works in the Body
Apigenin interacts with the body through several distinct pathways, which partly explains why people take it for different reasons.
For relaxation and anxiety, apigenin binds to the same receptor on brain cells that benzodiazepine drugs target. Some flavonoids have a selective affinity for this binding site, and apigenin’s calming reputation traces back to this interaction.11PubMed Central. Flavonoids as GABAA receptor ligands: the whole story? Molecular modeling studies show apigenin also has binding affinity for dopamine, serotonin, and other neurotransmitter receptors, suggesting its brain effects may involve multiple systems at once.12Clinical Neuropharmacology. Molecular Docking Analysis Reveals the Promising Role of Apigenin as a Potential Treatment for Neurological Disorders
For aging and metabolism, the main interest centers on an enzyme called CD38. As people age, CD38 levels tend to rise, which chews through NAD+, a molecule critical for energy metabolism and cellular repair. Apigenin inhibits CD38. In cell cultures and obese mice, apigenin treatment increased NAD+ levels and improved several markers of metabolic health, including glucose and lipid handling.13PubMed Central. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome The same CD38-inhibiting mechanism has shown protective effects on kidney cells under high-glucose conditions in diabetic rats, where apigenin restored the NAD+ balance and reduced oxidative damage.14PubMed Central. CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD(+)/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats
This CD38-NAD+ connection is the reason apigenin has become popular in the longevity supplement community. The logic is reasonable on paper: NAD+ declines with age, CD38 is one reason it declines, and apigenin inhibits CD38. But the human evidence that supplemental apigenin actually raises NAD+ levels in people, at any dose, does not yet exist in published form. The mechanism is plausible, the animal data is supportive, and the human confirmation is missing.
Drug Interactions Worth Knowing About
Apigenin inhibits certain liver enzymes that metabolize drugs. Specifically, it interferes with enzymes in the cytochrome P450 family, the same system that grapefruit juice disrupts.15Drug Metabolism and Disposition. Metabolism of Apigenin by Rat Liver Phase I and Phase II Enzymes and by Isolated Perfused Rat Liver It also inhibits another enzyme, CYP4F2, at concentrations achievable from dietary or supplemental intake, raising concern about interactions with drugs metabolized through these pathways.16PubMed. Food Polyphenol Apigenin Inhibits the Cytochrome P450 Monoxygenase Branch of the Arachidonic Acid Cascade
If you take medications that carry grapefruit warnings, that should be a flag for caution with apigenin supplements as well. Drugs for blood pressure, cholesterol, heart rhythm, and some psychiatric conditions are commonly metabolized through pathways that apigenin can slow down. Slowing drug metabolism means the drug lingers in your blood longer than expected, effectively increasing the dose you are exposed to. This is not a theoretical concern, it is the same mechanism behind well-documented grapefruit-drug interactions.
Hormonal Effects and Who Should Be Cautious
Apigenin acts as a partial agonist at estrogen receptors, meaning it can mimic estrogen weakly in some tissues and block it in others. In animal studies, it reversed uterine shrinkage caused by low estrogen and also modulated tissue changes caused by excessive estrogen, behaving as a kind of bidirectional regulator.17PubMed. Apigenin acts as a partial agonist action at estrogen receptors in vivo Separate research in immature rats confirmed that apigenin triggers estrogenic responses in uterine tissue, including increased gland formation.18PubMed. The estrogenic effects of apigenin, phloretin and myricetin based on uterotrophic assay in immature Wistar albino rats
This estrogenic activity matters for anyone with hormone-sensitive conditions. If you have or have had estrogen-receptor-positive breast cancer, endometriosis, or uterine fibroids, the partial estrogen activity of apigenin could theoretically worsen those conditions. The dietary amounts from food are almost certainly too small to matter, but supplement doses of 50 mg or more enter a range where the effect has not been ruled out in people. This is also relevant for men concerned about testosterone. While apigenin is sometimes marketed as supporting healthy testosterone levels, its estrogenic activity at higher doses complicates that narrative.
Brain Health Evidence From Animal Studies
The neuroprotection data is exclusively from animals, but it is worth mentioning because brain health is a major reason people buy apigenin supplements. In mice subjected to chronic stress, apigenin restored cognitive function and increased levels of brain-derived neurotrophic factor (BDNF), a protein that supports the survival and growth of brain cells.19PubMed. Apigenin exhibits memory enhancing activity through the restoration of oxido-endocrine balance and upregulation of BDNF/ERK/CREB signalling pathways in stressed mice Rats fed a high-fat, high-sugar diet also showed improved cognitive function and better brain insulin signaling when given apigenin, again through upregulation of the BDNF pathway.20Journal of Functional Foods. Apigenin modulates hippocampal CREB-BDNF signaling in high fat, high fructose diet-fed rats
These results are interesting but carry the usual caveat of animal research: the doses used are often far higher than what humans take in supplements, the route of administration varies, and rodent brains are not human brains. No one has run a controlled trial in people to see if apigenin supplements improve memory or protect against cognitive decline. The mechanistic plausibility is there, but the proof is not.
Getting More Apigenin From Food
If you prefer to boost apigenin intake through diet rather than supplements, how you prepare your food matters. Parsley is one of the richest sources, but cooking degrades some of its flavonoid content. When researchers added parsley to omelets and cooked them, only two of the flavonoids originally present in the raw herb survived the heat.21PubMed. Parsley (Petroselinum crispum Mill.): A source of bioactive compounds as a domestic strategy to minimize cholesterol oxidation during the thermal preparation of omelets Celery shows somewhat better retention. Thermal processing of celery at different pH levels converts some apigenin-related compounds into forms that may be easier or harder to absorb, depending on acidity. Free apigenin itself is most stable at acidic pH but degrades progressively in neutral conditions.22Food Chemistry. Effects of food formulation and thermal processing on flavones in celery and chamomile
The practical upshot: adding raw parsley as a garnish after cooking preserves more apigenin than cooking it into the dish. Celery holds up better to heat but still changes form. Chamomile tea, where the herb steeps in hot water for a few minutes rather than being boiled for hours, is probably the most studied and convenient dietary source. Even so, a cup of chamomile tea delivers a fraction of one milligram of apigenin. You would need many cups per day to approach even the low end of what clinical trials have tested.
Juicing also alters the picture. When parsley and celery are juiced, their natural enzymes convert apigenin compounds into different chemical forms before you even drink them. Acidification and heating of the juice then cause further conversions that may affect how well the apigenin is absorbed once it reaches your intestines.23Journal of Agricultural and Food Chemistry. Endogenous Enzymes, Heat, and pH Affect Flavone Profiles in Parsley (Petroselinum crispum var. neapolitanum) and Celery (Apium graveolens) during Juice Processing None of this makes dietary apigenin useless, but it does mean that the amount on a food-composition chart may not reflect what your body ultimately absorbs from a cooked dish or a processed juice.
Putting a Number on It When the Science Cannot
If you have read this far hoping for a confident dose recommendation, the honest answer remains frustrating. The best-studied dose range in humans comes from chamomile extract trials delivering roughly 8–10 mg of apigenin daily, split across multiple doses, for anxiety. Those trials showed few adverse effects and some benefit for anxious symptoms. The popular supplement dose of 50 mg daily has not been studied in a controlled human trial, but it falls far below the animal toxicity threshold and has accumulated a track record of anecdotal use without widespread reports of harm. Doses of several hundred milligrams and above start approaching the territory where animal data flags liver concerns, and the drug interaction and estrogen-receptor questions become harder to dismiss.
Reasonable people in the supplement world generally land somewhere between 25 and 50 mg per day for general use, taken with a meal to improve absorption. If your interest is specifically anxiety or sleep, the chamomile extract route has more clinical backing than isolated apigenin, even though it delivers a lower total apigenin dose. If your interest is NAD+ and longevity, you are betting on a mechanism that makes biological sense but has not yet been validated with human outcome data. And if you take prescription medications, especially those with CYP450 interactions, talk to a pharmacist before adding apigenin at any supplemental dose.